Emerging treatments in Castleman disease – a critical appraisal of siltuximab
Jean L Koff, Sagar Lonial Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA Abstract: Castleman disease (CD) is a rare, heterogeneous lymphoproliferative disorder for which no standard of care currently exists. Evidence that the pathophysiology of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-01-01
|
| Series: | Biologics : Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/emerging-treatments-in-castleman-disease-ndash-a-critical-appraisal-of-peer-reviewed-article-BTT |